CAPTRUST Financial Advisors’s Trillium Therapeutics Inc. TRIL Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-34	Closed	-$1K	–	5075
2021 Q3	$1K	Buy	+34	New	+$397	﹤0.01%	4552
2020 Q4	–	Sell	-1,000	Closed	-$15K	–	3578
2020 Q3	$15K	Buy	+1,000	New	+$9.97K	﹤0.01%	2117

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

CAPTRUST Financial Advisors's TRIL Position: Q4 2021 in Review

CAPTRUST Financial Advisors sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 34 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in TRIL in Q3 2020 and held it in 2 quarters. The position peaked at $15K in Q3 2020. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

CAPTRUST Financial Advisors reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
CAPTRUST Financial Advisors sold 34 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $1K.
CAPTRUST Financial Advisors first reported a position in Trillium Therapeutics Inc. in Q3 2020 and held it in 2 quarters.
CAPTRUST Financial Advisors's Trillium Therapeutics Inc. position peaked at $15K in Q3 2020.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.